Characteristics of general practitioners who frequently see drug industry representatives: National cross sectional study

Chris Watkins, Laurence Moore, Ian Harvey, Patricia Carthy, Elizabeth Robinson, Richard Brawn

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Variation in prescribing costs between general practitioners is well documented. We previously found that frequent general practitioner contact with drug industry representatives was strongly and independently associated with higher prescribing costs. This paper describes the attitudes and behaviour of general practitioners who report seeing drug representatives frequently.
Original languageEnglish
Pages (from-to)1178-1179
Number of pages2
JournalBritish Medical Journal
Volume326
Issue number7400
DOIs
Publication statusPublished - 29 May 2003

Cite this